Research Suggests GLP-1 Medications Could Prevent Breast Cancer

University of Pennsylvania study shows GLP-1 meds reduce breast cancer risk by 30-35% in overweight women.
Analysis of 111,000 women found 30.5% lower odds of breast cancer diagnosis in GLP-1 users.
Study suggests GLP-1 drugs may lower risk by reducing weight and inflammation.
Researchers seek funding for clinical trials to test if GLP-1 meds prevent breast cancer.
Dr. Gilberto Lopes recommends preventive use for high-risk women needing weight loss.
Further testing is needed before changing clinical strategies.

Health | Research | Medicine

United States

Professor Elizabeth McDonald | Dr. Gilberto Lopes

1 hour ago